Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Arch Dis Child Fetal Neonatal Ed ; 108(4): 360-366, 2023 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-36653173

RESUMO

BACKGROUND: Preterm infants commonly receive red blood cell (RBC), platelet and fresh frozen plasma (FFP) transfusions. The aim of this Neonatal Transfusion Network survey was to describe current transfusion practices in Europe and to compare our findings to three recent randomised controlled trials to understand how clinical practice relates to the trial data. METHODS: From October to December 2020, we performed an online survey among 597 neonatal intensive care units (NICUs) caring for infants with a gestational age (GA) of <32 weeks in 18 European countries. RESULTS: Responses from 343 NICUs (response rate: 57%) are presented and showed substantial variation in clinical practice. For RBC transfusions, 70% of NICUs transfused at thresholds above the restrictive thresholds tested in the recent trials and 22% below the restrictive thresholds. For platelet transfusions, 57% of NICUs transfused at platelet count thresholds above 25×109/L in non-bleeding infants of GA of <28 weeks, while the 25×109/L threshold was associated with a lower risk of harm in a recent trial. FFP transfusions were administered for coagulopathy without active bleeding in 39% and for hypotension in 25% of NICUs. Transfusion volume, duration and rate varied by factors up to several folds between NICUs. CONCLUSIONS: Transfusion thresholds and aspects of administration vary widely across European NICUs. In general, transfusion thresholds used tend to be more liberal compared with data from recent trials supporting the use of more restrictive thresholds. Further research is needed to identify the barriers and enablers to incorporation of recent trial findings into neonatal transfusion practice.


Assuntos
Transfusão de Sangue , Recém-Nascido Prematuro , Lactente , Recém-Nascido , Humanos , Transfusão de Eritrócitos , Hemorragia , Unidades de Terapia Intensiva Neonatal , Transfusão de Plaquetas
2.
Arch Dis Child Fetal Neonatal Ed ; 107(3): 293-298, 2022 May.
Artigo em Inglês | MEDLINE | ID: mdl-34344835

RESUMO

OBJECTIVE: To assess the reliability, accuracy and precision of distal end-tidal capnography (detCO2) in neonates compared with transcutaneous (tcCO2) carbon dioxide measurements. DESIGN: Observational, prospective clinical study. SETTING: Neonatal intensive care unit at Medical University of Vienna. PARTICIPANTS: Conventionally ventilated neonates with a body weight between 1000 g and 3000 g. INTERVENTION: End-tidal partial pressure of CO2 was measured in distal position using the separate lumen of a double-lumen endotracheal tube connected to an external side-stream capnometer. Three consecutive detCO2 and tcCO2 values were recorded simultaneously and compared with simultaneous arterialised partial pressure of CO2 (paCO2) measurements in each patient. MAIN OUTCOME MEASURES: Reliability, accuracy and precision of detCO2 and tcCO2 measurements compared with paCO2 in neonates. RESULTS: Twenty-five neonates were included with a median (range) weight at enrolment of 1410 (1010-2980) g, from which 81 simultaneous measurements of detCO2, tcCO2 and paCO2 were obtained. The mean (SD) of paCO2, detCO2 and tcCO2 was 45.0 (8.6) mmHg, 42.4 (8.4) mmHg and 50.4 (20.4) mmHg, respectively. The intraclass correlation between paCO2 and detCO2 and between paCO2 and tcCO2 reached 0.80 (95% CI 0.71 to 0.87, p<0.001) and 0.59 (95% CI 0.43 to 0.72, p<0.001), respectively. In the Bland-Altman analysis, bias and precision of detCO2 with respect to paCO2 amounted to -2.68 mmHg and 10.62 mmHg (95% CI 8.49 to 14.51), respectively. Bias and precision of tcCO2 with respect to paCO2 amounted to 5.39 mmHg and 17.22 mmHg (95% CI 13.21 to 23.34), respectively. CONCLUSION: DetCO2 had better reliability, accuracy and precision with paCO2 than tcCO2 in ventilated neonates without severe lung diseas. TRIAL REGISTRATION NUMBER: NCT03758313.


Assuntos
Dióxido de Carbono , Respiração Artificial , Capnografia/métodos , Humanos , Recém-Nascido , Monitorização Fisiológica/métodos , Estudos Prospectivos , Reprodutibilidade dos Testes , Respiração Artificial/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA